IL6 and chronic obstructive pulmonary disease: In another clinical trial, doxycycline was found to be ineffective in lowering MMP-8 and 9, IL-6, and IL-8 concentrations and in improving lung function parameters; however, it did decrease systemic inflammation in COPD patients [21].